Total Liabilities for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported total liabilities is $19.20B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$19.20B
YoY change
+10.4%
5Y CAGR
+4.4%
Peak year (2025)
$19.20B
Latest annual
$19.20B
Total Liabilities history chart for Boston Scientific (BSX) from 1991 to 2025
Total Liabilities history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $19.20B | +10.4% | ||
| 2024 | $17.39B | +11.4% | ||
| 2023 | $15.61B | +4.8% | ||
| 2022 | $14.90B | -4.6% | ||
| 2021 | $15.61B | +1.0% | ||
| 2020 | $15.45B | -7.4% | ||
| 2019 | $16.69B | +36.0% | ||
| 2018 | $12.27B | +2.0% | ||
| 2017 | $12.03B | +5.9% | ||
| 2016 | $11.36B | -3.8% | ||
| 2015 | $11.81B | +18.3% | ||
| 2014 | $9.99B | -2.0% | ||
| 2013 | $10.20B | -0.9% | ||
| 2012 | $10.28B | +3.5% | ||
| 2011 | $9.94B | -8.3% | ||
| 2010 | $10.83B | -15.9% | ||
| 2009 | $12.88B | -7.6% | ||
| 2008 | $13.94B | -13.4% | ||
| 2007 | $16.10B | +1.9% | ||
| 2006 | $15.80B | +303.6% | ||
| 2005 | $3.91B | -5.6% | ||
| 2004 | $4.14B | +46.1% | ||
| 2003 | $2.84B | +43.1% | ||
| 2002 | $1.98B | +1.2% | ||
| 2001 | $1.96B | +31.3% | ||
| 2000 | $1.49B | -19.3% | ||
| 1999 | $1.85B | -39.8% | ||
| 1998 | $3.07B | +212.9% | ||
| 1997 | $981.60M | +64.8% | ||
| 1996 | $595.80M | +85.0% | ||
| 1995 | $322.00M | +250.8% | ||
| 1994 | $91.80M | +20.0% | ||
| 1993 | $76.50M | +53.0% | ||
| 1992 | $50.00M | +6.2% | ||
| 1991 | $47.10M | — |
Total Liabilities values are taken from Boston Scientific's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Boston Scientific (BSX) most recent annual total liabilities stands at $19.20B (2025) – grew 10.4% year-over-year.
Boston Scientific total liabilities compound annual growth for the 2020–2025 (5 years) window is +4.4%, with the latest reading among the more recent periods of the dataset.
The highest annual total liabilities of $19.20B was reported in 2025. The lowest in the available history was $47.10M in 1991.
Within Healthcare, Boston Scientific (BSX) ranks 9th among 8 peers we track. The peer median for total liabilities is $101.80B.
Boston Scientific Total Liabilities by Year
Boston Scientific Total Liabilities 2025: $19.20B
Boston Scientific total liabilities in 2025 was $19.20B, grew 10.4% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Total Liabilities 2024: $17.39B
Boston Scientific total liabilities in 2024 was $17.39B, grew 11.4% from 2023.
Boston Scientific Total Liabilities 2023: $15.61B
Boston Scientific total liabilities in 2023 was $15.61B, edged up 4.8% from 2022.
Boston Scientific Total Liabilities 2022: $14.90B
Boston Scientific total liabilities in 2022 was $14.90B, edged down 4.6% below 2021.
Boston Scientific Total Liabilities 2021: $15.61B
Boston Scientific total liabilities in 2021 was $15.61B.
See more financial history for Boston Scientific (BSX).
Sector peers — Total Liabilities
Companies in the same sector as Boston Scientific, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Boston Scientific's total liabilities?
- Latest reported total liabilities for Boston Scientific (BSX) is $19.20B (period ending December 31, 2025).
How has Boston Scientific total liabilities changed year-over-year?
- Boston Scientific (BSX) total liabilities changed +10.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific total liabilities?
- Boston Scientific (BSX) total liabilities compound annual growth rate is +4.4% over the most recent 5 years available.
When did Boston Scientific total liabilities hit its highest annual value?
- Boston Scientific total liabilities reached its highest annual value of $19.20B in 2025.
What was Boston Scientific total liabilities in 2024?
- Boston Scientific (BSX) total liabilities in 2024 was $17.39B.
What was Boston Scientific total liabilities in 2025?
- Boston Scientific (BSX) total liabilities in 2025 was $19.20B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.